JT

Jitendra Trivedi Kumar

Active Director Director DIN 08042096
DIN 08042096 First appointment Apr 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Jitendra Trivedi Kumar

Data last updated:

Jitendra Trivedi Kumar is a Director at Medsan Biotech Private Limited (since 2018). The company operates in Business Services.

DIN 08042096
Primary Designation Director
Industry Business Services
First Appointment 09 Apr 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medsan Biotech Private Limited U74999RJ2018PTC060851
Director09 Apr 20182018Active

Board colleagues of Jitendra Trivedi Kumar

Directorship timeline

Open interactive timeline →
Medsan Biotech Private Limited
Premium access

Shareholding and investment profile for Jitendra Trivedi Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Trivedi Kumar

Jitendra Trivedi Kumar currently holds 1 directorship: Medsan Biotech Private Limited (Director, since 09 Apr 2018).

Jitendra Trivedi Kumar was first appointed on 09 Apr 2018 as Director at Medsan Biotech Private Limited.

The current boards of Jitendra Trivedi Kumar's companies include Chirag Prasad Trivedi (Medsan Biotech Private Limited), Lalit Kumar Vaishnav (Medsan Biotech Private Limited), Pallavi Shrimali (Medsan Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available